SOCS3 and inflammatory bowel disease: IL-24 exerts anti-inflammatory effects in a variety of autoimmune diseases, including inflammatory bowel disease (IBD) and experimental autoimmune uveitis (EAU), by activating SOCS3 [22, 23].